Medicines List

Description

Co-Irbesso is a fixed-dose combination of an angiotensin-II receptor antagonist – irbesartan, and a thiazide diuretic – hydrochlorothiazide. The combination of these two ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone.

Indications

Co-Irbesso is indicated:
– for treatment of essential hypertension;
– in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

Subject to medical prescription.

Concentrations and pharmaceutical form: 150 mg/12.5 mg, 300 mg/12.5 mg film-coated tablets

Description

Buto-Asma is a pressurized suspension for inhalation and contains the active substance salbutamol as sulphate.
Salbutamol belongs to the group of bronchodilators (drugs that dilate the bronchi, facilitate breathing and soothe coughs).

Indications

Buto-Asma is used for:
– Symptomatic treatment of bronchospasm in patients with bronchial asthma and similar conditions associated with reversible airway obstruction;
– Prevention of bronchospasm induced by exercise or exposure to allergic attack.

Subject to medical prescription.

Concentration and pharmaceutical form: 0,1 mg/dose pressurised inhalation, suspension

Description

Simvacor contains the active substance simvastatin and belongs to class of medicines called “statins”. Simvacor is a medicine used to lower levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood.

Indications

Hypercholesterolaemia
Simvacor is indicated for treatment of primary hypercholesterolaemia or mixed dyslipidaemia, as an adjunct to diet, when response to diet and other non-pharmacological treatments (e.g. exercise, weight reduction) is inadequate. Treatment of homozygous familial hypercholesterolaemia (HoFH) as an adjunct to diet and other lipid-lowering treatments (e.g. LDL apheresis) or if such treatments are not appropriate.

Cardiovascular prevention
Reduction of cardiovascular mortality and morbidity in patients with manifest atherosclerotic cardiovascular disease or diabetes mellitus, with either normal or increased cholesterol levels, as an adjunct to correction of other risk factors and other cardioprotective therapy.

Subject to medical prescription.

Concentration and pharmaceutical form: 10 mg, 20 mg, 40 mg film-coated tablets

Description

Irbesso belongs to a group of medicines known as angiotensin-II receptor antagonists and prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax and the blood pressure to lower. Irbesso slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.

Indications

Irbesso is indicated for:
– treatment of essential hypertension;
– treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus as part of an antihypertensive medicinal product regimen.

Subject to medical prescription.

Concentration and pharmaceutical form: 150 mg, 300 mg film-coated tablets